In line with this concept, Teff-derived TNFa has been shown to boost Tregs, dependent upon TNFR2 expression on Tregs, in experimental models of diabetes (95) and graft-vs-host disease (GvHD) (96). The gene discussed is TNFRSF1B; the disease is graft versus host disease.